OpenAI granted vetted developers and U.S. government partners access to GPT-Rosalind. This specialized model targets biodefense, public health, and pandemic preparedness. The move restricts high-risk capabilities to trusted entities to prevent misuse. Practitioners in biosafety can now leverage frontier AI for critical defense research without risking public exposure of dangerous biological insights.